Functional recovery after lesions of the nervous system. IV. Structural correlates of recovery in adult subjects. Changes in drug sensitivity during recovery of function after brain damage.
D000661:Amphetamine / Q000627:therapeutic use; D000818:Animals; D001058:Apomorphine / Q000627:therapeutic use; D001921:Brain / Q000503:physiopathology*; D001930:Brain Injuries / Q000188:drug therapy / Q000503:physiopathology* / Q000534:rehabilitation; D001931:Brain Mapping; D003342:Corpus Striatum / Q000293:injuries; D005625:Frontal Lobe / Q000293:injuries; D008124:Locomotion; D009069:Movement Disorders / Q000188:drug therapy / Q000517:prevention & control; D009434:Neural Pathways; D018377:Neurotransmitter Agents; D009638:Norepinephrine / Q000627:therapeutic use; D051381:Rats; D013378:Substantia Nigra / Q000293:injuries; D009435:Synaptic Transmission; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D018377:Neurotransmitter Agents; D000661:Amphetamine; D014446:Tyrosine 3-Monooxygenase; D001058:Apomorphine; D009638:Norepinephrine